Public Puts Pressure On Hengrui Medicine To Address Quality Issues
This article was originally published in PharmAsia News
Executive Summary
After facing a lawsuit by Sanofi-Aventis over patent infringement, Hengrui Medicine now faces another challenge with reports of quality issues from Zhejiang Province State FDA